Sarcoma  >>  R-(-)-gossypol (AT 101)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
R-(-)-gossypol (AT 101) / Ascentage Pharma
NCT00540722: Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

Completed
2
56
US
R-(-)-gossypol acetic acid, AT-101, laboratory biomarker analysis
National Cancer Institute (NCI)
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
06/12
06/12

Download Options